Description
RADIOPHARMACEUTICALS
First action · last action
2025-02-14 · 2026-06-29
Transactions
3
First transaction's obligation
$514,986
Base + all options value (sum of deltas)
$109,120
Extent competed
COMPETED UNDER SAP
Other than full & open authority
—
Set-aside
—
Offers received
—
SDVOSB flag on record
No
Parent IDV
36C24624D0038
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
Modification chain · 3 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2025-02-14+$514,986= $514,986
- Mod P000012025-12-01+$1,075= $516,061
- Mod P000022026-06-29-$406,940= $109,120
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2025-02-14 | +$514,986 | $514,986 | RADIOPHARMACEUTICALS |
| Mod P00001· FUNDING ONLY ACTION | 2025-12-01 | +$1,075 | $516,061 | RADIOPHARMACEUTICALS |
| Mod P00002· FUNDING ONLY ACTION | 2026-06-29 | −$406,940 | $109,120 | RADIOPHARMACEUTICALS |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI ZL79MXYVNDM1)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C24726P0672 | 247-NETWORK CONTRACT OFFICE 7 (36C247) · Q527 · MEDICAL- NUCLEAR MEDICINE | $112,908 | FY2026 |
| 36C25926N0360 | NETWORK CONTRACT OFFICE 19 (36C259) · 6505 · DRUGS AND BIOLOGICALS | $151,197 | FY2026 |
| 36C25926D0048 | NETWORK CONTRACT OFFICE 19 (36C259) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2026 |
| 36C26026N0258 | 260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS | $122,387 | FY2026 |
| 36C24426N0682 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6505 · DRUGS AND BIOLOGICALS | $590,927 | FY2026 |
| 36C25026N0520 | 250-NETWORK CONTRACT OFFICE 10 (36C250) · 6505 · DRUGS AND BIOLOGICALS | $310,000 | FY2026 |
Other recipients under 6505 from 246-NETWORK CONTRACTING OFFICE 6 (36C246) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C24626N1034 | PARTNER THERAPEUTICS, INC. | 246-NETWORK CONTRACTING OFFICE 6 (36C246) | $72,362 | FY2026 |
| 36C24626N0890 | PROGENICS PHARMACEUTICALS INC | 246-NETWORK CONTRACTING OFFICE 6 (36C246) | $1,212,530 | FY2026 |
| 36C24626A0027 | PROGENICS PHARMACEUTICALS INC | 246-NETWORK CONTRACTING OFFICE 6 (36C246) | $0 | FY2026 |
| 36C24626N0782 | PARTNER THERAPEUTICS, INC. | 246-NETWORK CONTRACTING OFFICE 6 (36C246) | $72,563 | FY2026 |
| 36C24626N0690 | PARTNER THERAPEUTICS, INC. | 246-NETWORK CONTRACTING OFFICE 6 (36C246) | $54,422 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C24625N0478_3600_36C24624D0038_3600 · retrieved 2026-09-26.